BSE filing, NSE: SAKUMA. Summary written from the filing by ALFA Finder's alert engine.
Sakuma Exports Ltd: key numbers
- Share price
- ₹1.67
- Market cap
- ₹261.8 Cr
- Revenue (annual)
- ₹1,708 Cr
- Net profit (annual)
- ₹9.51 Cr
- P/E (TTM)
- 24.5×Sector 36.4×
- Promoter holding
- 46.29%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sakuma Exports Ltd
All →Sakuma Exports Preferential Issue
Sakuma Exports issued an EGM notice for 21 Nov 2026 to approve a preferential equity issue. The sole agenda item is a special resolution for preferential allotment.
Sakuma Exports Preferential Issue
Sakuma Exports seeks EGM approval for a Rs 107.90 Crore preferential issue of up to 65 crore shares at Rs 1.66. Nine named allottees are proposed.
- Value
- ₹107.9 Cr
Sakuma Exports Fund Raise of ₹107.9 Cr
Sakuma Exports approved a preferential issue of 65 crore shares at Rs.1.66 each. It raises Rs.107.90 Crore, subject to shareholder approval at the November 2026 EGM.
- Value
- ₹107.9 Cr
Sakuma Exports Board Meeting Date
Sakuma Exports scheduled a board meeting for October 23, 2026, to consider a fund-raising proposal. No specific amount or mode has been determined yet.
Sakuma Exports Annual General Meeting
Sakuma Exports Limited held its 21st Annual General Meeting on September 29, 2026. Shareholders discussed the adoption of annual financial statements and re-appointment of a director.
Sakuma Exports Board Meeting Date
Sakuma Exports Ltd intimated a Board Meeting scheduled for September 30, 2026. The agenda includes considering a fund-raising proposal through equity or other securities.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.